Cannabichromene (CBC) Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 92 studies associated with Cannabichromene (CBC).
Here is a small sampling of Cannabichromene (CBC) studies by title:
- Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder
- In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters
- In Silico Binding Analysis of Cannabinoids with Eph Receptors for Therapeutic Use in Gliomas
- Industrial Hemp ( Cannabis sativa L.) Inflorescences as Novel Food: The Effect of Different Agronomical Practices on Chemical Profile
- Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway
Components of the Cannabichromene (CBC) Research Dashboard
- Top medical conditions associated with Cannabichromene (CBC)
- Proven effects in clinical trials for Cannabichromene (CBC)
- Receptors associated with Cannabichromene (CBC)
- Individual study details for Cannabichromene (CBC)
Ready to become a subscriber? Go to our PRICING page.
Page Quick Links
Select New Cannabinoid
Overview - Cannabichromene (CBC)
Description of Cannabichromene (CBC)
Cannabichrome (CBC) was discovered in 1966 and by 2016 there were a total of nine distinct members in the CBC family.
One of its unique characteristic is that CBC is a relatively stable cannabinoid that has been found in century-old samples of cannabis.
Other Names:
CannabichromeneCannabichrome, Cannanbichromene, Pentylcannabichromene, (+/-)-Cannabichromene plus numerous other supplier-based synonyms.
IUPAC Name: 2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol
Molecular Formula: C21H30O2
Source–PubChem
Cannabichromene (CBC) Properties and Effects
CBC may:
- CBC not a substrate or inhibitor of ABCB1 or ABCG2 (M. Etchart et al., 2022)
- Produced potent anticonvulsant effects in Dravet model (L. Anderson et al., 2021)
- Reduce inflammation associated with ARDS (H. Khodadadi et al., 2021)
- Ameliorate colitis (B. Romano et al., 2013)
- Neuroprotective in cases of epilepsy, Huntington's, Parkinson's (N. Stone et al., 2020)
- Reduce inflammation (M. Udoh et al., 2019)
- Induce antidepressant-like/mood elevating effect (A. El-Alfy et al., 2010)
- Potent antibacterial activity against MRSA (G. Appendino et al., 2008)
- Inhibit breast cancer cell growth (A. Ligresti et al., 2006)
Cannabichromene (CBC) Receptor Binding
Endocannabinoid System (ECS) and CBC:
- CB1 no known activity (M. Udoh et al., 2019)
- CB2 agonist (M. Udoh et al., 2019)
Endocannabinoidome (eCBome) and CBC:
- CBC may increase expression of TRPA1 (H. Khodadadi et al., 2021)
- CBC may increase expression of TRPV2 (H. Khodadadi et al., 2021)
- TRPA1 agonist (B. Romano et al., 2013; L. De Petrocellis et al., 2011)
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
